Navigation Links
Mayo Clinic finds steroids may shorten hospital stay for pneumonia patients
Date:2/28/2013

ROCHESTER, Minn. Patients with pneumonia may spend fewer days in the hospital if they are given steroids along with antibiotics and supportive care. That's the finding of a Mayo Clinic analysis of eight randomized-controlled clinical trials involving more than 1,100 patients. The results appear in the March issue of the Journal of Hospital Medicine.

"Given that the average hospital stay for community-acquired pneumonia can range from nine to 23 days, the prospect of speeding recovery, even by a day or two, is helpful," says co-author M. Rizwan Sohail, M.D., a Mayo infectious disease specialist.

Pneumonia is a major health risk, especially in the elderly, the very young and those with chronic lung diseases. Five percent to 15 percent of pneumonia patients die from it, depending on its severity and the treatment administered, recent studies report.

Mayo researchers reviewed eight clinical trials conducted from 2000 to 2011. Most of the research studied patients between 60 and 80. While steroid use didn't prevent deaths, for those who survived the pneumonia, it reduced their hospital stays an average of 1.21 days.

The researchers say that while the findings are significant, the data were not strong enough for them to recommend routine use of steroids for pneumonia patients; more study is needed. They add that continuing any steroids patients may already be taking is reasonable.

The study was led by Majid Shafiq, M.D., a former Mayo Clinic researcher currently at Johns Hopkins University.

A similar, but unrelated study by A.R. Khan, M.D., involving researchers at Mayo Clinic and other institutions, found that use of certain lipid-lowering medicines, commonly referred to as statins, may have a role in reducing the risk of developing community-acquired pneumonia and associated mortality. That study, published last month in PLOS ONE, reviewed 18 clinical trials. The evidence was considered less r
'/>"/>

Contact: Robert Nellis
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Vein Expert in Winston-Salem, NC Participates in Elite Cleveland Clinic Seminar
2. Renew Health and Wellness, a Hormone Replacement and Weight Loss Clinic Based in St. Louis, MO, Announces the Addition of Tara Smith, NP, to Their Staff of Professionals
3. Cleveland Clinic study shows bariatric surgery restores pancreatic function by targeting belly fat
4. Cleveland Clinic researcher receives grant to fund autism research
5. Sixty HealthLine Systems, Inc. Clients Honored as Healthgrades 2013 Distinguished Hospitals for Clinical Excellence
6. PCTRE meeting: 2-way communication between the bench and the clinic
7. SEO Crucial For Retail Clinics and Physician Owned Private Practices
8. Birmingham Maple Clinic Reports New Video Game May Help Treat Schizophrenia
9. Case Western Reserve University joins BrainGate clinical trial
10. Combo of Avastin, second drug shows promise fighting brain cancer, Mayo Clinic finds
11. Maturitas publishes a clinical guide on lichen sclerosus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... According to a new market research report ... Naval), Application (Software Defined Radios, SATCOM, Encryption, Smartphones, ... Asia-Pacific, Europe, the Middle East & ROW) - ... market is estimated to be $30.15 billion in ... of 5.56% to reach $39.52 billion by 2019 ...
(Date:7/10/2014)... A Forever Recovery , an open-ended ... to a great start and gives them a solid ... a new Eating Disorders section of its website at ... , Different types of eating disorders listed ... (DSM-IV), including anorexia nervosa, bulimia nervosa, and EDNOS (Eating ...
(Date:7/10/2014)... electronic health record becomes widespread across the United States, ... Care Act, the quantity of clinical data that will ... dramatically increase. Additionally, experts in healthcare have become ... of data for the purpose of gleaning insights that ... care a process that is known as big ...
(Date:7/10/2014)... Teens who are sensitive to light or noise after ... such as anxiety and depression, a new study says. ... issues teens experience after concussion may help in planning ... when to return to play and what accommodations are ... Koehl and Dong Han, of the University of Kentucky ...
(Date:7/10/2014)... Dennis Thompson HealthDay Reporter ... out of 10 adults make use of calorie information on ... restaurants, according to a new U.S. study. Women in ... Seung Hee Lee-Kwan, an epidemiologist with the U.S. Centers for ... said they used menu labeling to help choose their meal, ...
Breaking Medicine News(10 mins):Health News:Portable Communication Systems Market Projected to Reach $39.52 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Portable Communication Systems Market Projected to Reach $39.52 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Portable Communication Systems Market Projected to Reach $39.52 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Latest A Forever Recovery Launches Eating Disorders Section on Website 2Health News:Six cases where big data can reduce healthcare costs 2Health News:Six cases where big data can reduce healthcare costs 3Health News:Six cases where big data can reduce healthcare costs 4Health News:Some Teens May Face Emotional Problems After Concussion 2Health News:60 Percent of Diners Use Calorie Labeling When Posted: CDC 2Health News:60 Percent of Diners Use Calorie Labeling When Posted: CDC 3
... Institute, a,leading healthcare career training provider, has announced John ... company,s board of directors.,Hopkins, currently the company,s chief executive ... during the board,s Feb. 4th meeting. , ... The consolidation of leadership roles ...
... (OTC Bulletin Board: MLSS), the recognized leader in advanced ... at the upcoming Chicago Dental Society,s 144th Midwinter Meeting ... sales of the STA Single Tooth Anesthesia System ... with four successive quarters of sales growth in 2008, ...
... babies and parents through the worst of teethingTHOUSAND OAKS, ... relief for their children, the options have been limited ... retailers who sell baby products have a groundbreaking therapeutic ... desperately seeking relief for their babies. The technology behind ...
... Provides Additional Free Resources to support Customer,s Weight ... leading provider of weight management products and services, ... with improved usability, new information architecture and visual ... that supports NutriSystem customers and new dieters to ...
... Physicians in Particular, According to New Report from ... a leading provider of managed care market intelligence, ... a number of challenges in the coming year, ... the new Orange County Market Overview , ...
... performing western blots -- a popular analytical technique used to ... ... CT (Vocus) February 23, 2009 -- Carestream Molecular Imaging, a ... for performing western blots -- a popular analytical ...
Cached Medicine News:Health News:MedVance Institute Promotes John L. Hopkins to Chairman of the Board of Directors 2Health News:Milestone Scientific to Exhibit at the Chicago Dental Society's 144th Midwinter Meeting 2Health News:Milestone Scientific to Exhibit at the Chicago Dental Society's 144th Midwinter Meeting 3Health News:Milestone Scientific to Exhibit at the Chicago Dental Society's 144th Midwinter Meeting 4Health News:Groundbreaking JeJe Teether Vibrates Pain Safely Away 2Health News:Groundbreaking JeJe Teether Vibrates Pain Safely Away 3Health News:NutriSystem.com Gets a Complete Makeover 2Health News:NutriSystem.com Gets a Complete Makeover 3Health News:NutriSystem.com Gets a Complete Makeover 4Health News:Regulations Against Balance Billing to Impact Orange County, Calif., Physicians' Bottom Line 2Health News:Carestream Molecular Imaging Releases Western Blot Kits For Added Convenience, Better Performance 2Health News:Carestream Molecular Imaging Releases Western Blot Kits For Added Convenience, Better Performance 3
(Date:1/15/2014)... 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ECTE ... CGM System as a non-invasive, wireless continuous glucose monitoring ... Executive Chairman and Interim CEO of Echo Therapeutics, will ... Equity Conference. Mr. Doman will make ...
(Date:1/15/2014)... NEW YORK , Jan. 15, 2014 ... research report is available in its catalogue: ... & Forecast – Worldwide Analysis ... Pump Market Analysis ...
(Date:1/15/2014)... 15, 2014 Reportlinker.com announces that a ... its catalogue: Global ... Systems -- Focus on End Users ... OBJECTIVES A drug delivery system ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18
... Showed Significantly Improved Functioning Within Three ... ... Nearly half of patients,with schizophrenia fail to remain on their medication ... from a new international,study showed that patients treated with risperidone long-acting ...
... Phase III Clinical Trial of Acetavance(TM) for the Treatment of ... ... Trial of Omigard(TM) Completes Patient Enrollment, SAN DIEGO, May ... company focused on in-licensing,developing and commercializing proprietary product candidates principally,for ...
Cached Medicine Technology:Patients Treated with Risperidone Long-Acting Injection had a Significantly Longer Time to Relapse Compared to Quetiapine in International Clinical Study 2Patients Treated with Risperidone Long-Acting Injection had a Significantly Longer Time to Relapse Compared to Quetiapine in International Clinical Study 3Patients Treated with Risperidone Long-Acting Injection had a Significantly Longer Time to Relapse Compared to Quetiapine in International Clinical Study 4Patients Treated with Risperidone Long-Acting Injection had a Significantly Longer Time to Relapse Compared to Quetiapine in International Clinical Study 5Patients Treated with Risperidone Long-Acting Injection had a Significantly Longer Time to Relapse Compared to Quetiapine in International Clinical Study 6Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update 2Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update 3Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update 4Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update 5Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update 6Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update 7Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update 8Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update 9
Premium Full Color Digital Ultrasound...
... The new ACUSON CV70 cardiovascular ultrasound ... capabilities in a powerful, all-digital ultrasound ... sensitivity, color flow sensitivity and spatial ... the ACUSON family of cardiovascular products. ...
Aplio was designed for intuitive operation so you can get the results you are looking for quickly and easily. From customizable measurement packages to an ergonomic platform design, Aplio was built m...
AngioSpeed V series, it is an Angiography system designed for vascular treatment in various radiological regions, cardiology, and neurology. SHIMADZU brings you a single system with all units fused t...
Medicine Products: